$GENZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENZYME CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENZYME CORP. Get notifications about new insider transactions in GENZYME CORP for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 10 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 02 2010 | GENZ | GENZYME CORP | Amello Jason | Corp Contrllr,Chief ... | Option Exercise | M | 46.24 | 6,640 | 307,034 | 0 | |
Sep 02 2010 | GENZ | GENZYME CORP | Amello Jason | Corp Contrllr,Chief ... | Sell | S | 70.30 | 6,640 | 466,792 | 3,270 | 9.9 K to 3.3 K (-67.00 %) |
Sep 02 2010 | GENZ | GENZYME CORP | Amello Jason | Corp Contrllr,Chief ... | Buy | M | 46.24 | 6,640 | 307,034 | 9,910 | 3.3 K to 9.9 K (+203.06 %) |
Jul 27 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | M | 43.90 | 22,800 | 1,000,920 | 0 | |
Jul 27 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | M | 46.24 | 9,000 | 416,160 | 0 | |
Jul 27 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | M | 41.50 | 241 | 10,002 | 0 | |
Jul 27 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Sell | S | 63.75 | 20,741 | 1,322,239 | 20,671 | 41.4 K to 20.7 K (-50.08 %) |
Jul 27 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Sell | S | 66.10 | 9,000 | 594,900 | 41,412 | 50.4 K to 41.4 K (-17.85 %) |
Jul 27 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Sell | S | 63.75 | 2,300 | 146,625 | 50,412 | 52.7 K to 50.4 K (-4.36 %) |
Jul 27 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Buy | M | 41.50 | 241 | 10,002 | 52,712 | 52.5 K to 52.7 K (+0.46 %) |
Jul 27 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Buy | M | 46.24 | 9,000 | 416,160 | 52,471 | 43.5 K to 52.5 K (+20.70 %) |
Jul 27 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Buy | M | 43.90 | 22,800 | 1,000,920 | 43,471 | 20.7 K to 43.5 K (+110.30 %) |
Jul 14 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | M | 39.23 | 23,746 | 931,556 | 0 | |
Jul 14 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | M | 32.69 | 40,000 | 1,307,600 | 0 | |
Jul 14 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Sell | S | 53.82 | 63,746 | 3,430,810 | 12,663 | 76.4 K to 12.7 K (-83.43 %) |
Jul 14 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Buy | M | 39.23 | 23,746 | 931,556 | 76,409 | 52.7 K to 76.4 K (+45.09 %) |
Jul 14 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Buy | M | 32.69 | 40,000 | 1,307,600 | 52,663 | 12.7 K to 52.7 K (+315.88 %) |
Jul 02 2010 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 0.00 | 504 | 0 | 504 | |
Jul 02 2010 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 0.00 | 582 | 0 | 582 | |
Jun 18 2010 | GENZ | GENZYME CORP | FENTON DENNIS M | Director | Option Exercise | A | 51.52 | 7,125 | 367,080 | 7,125 | |
Jun 18 2010 | GENZ | GENZYME CORP | FENTON DENNIS M | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Jun 18 2010 | GENZ | GENZYME CORP | Burakoff Steven | Director | Option Exercise | A | 51.52 | 7,125 | 367,080 | 7,125 | |
Jun 18 2010 | GENZ | GENZYME CORP | Burakoff Steven | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Jun 18 2010 | GENZ | GENZYME CORP | Ende Eric J | Director | Option Exercise | A | 51.52 | 7,125 | 367,080 | 7,125 | |
Jun 18 2010 | GENZ | GENZYME CORP | Ende Eric J | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Jun 18 2010 | GENZ | GENZYME CORP | WHITWORTH RALPH V | Director | Option Exercise | A | 51.52 | 7,125 | 367,080 | 7,125 | |
Jun 18 2010 | GENZ | GENZYME CORP | WHITWORTH RALPH V | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Jun 18 2010 | GENZ | GENZYME CORP | WHITWORTH RALPH V | Director | Option Exercise | M | 0.00 | 2,375 | 0 | 0 | |
Jun 18 2010 | GENZ | GENZYME CORP | WHITWORTH RALPH V | Director | Buy | M | 0.00 | 2,375 | 0 | 2,375 | 0 to 2.4 K |
Jun 18 2010 | GENZ | GENZYME CORP | SYRON RICHARD F/CA | Director | Option Exercise | A | 51.52 | 7,125 | 367,080 | 7,125 | |
Jun 18 2010 | GENZ | GENZYME CORP | SYRON RICHARD F/CA | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
Jun 18 2010 | GENZ | GENZYME CORP | SYRON RICHARD F/CA | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Jun 18 2010 | GENZ | GENZYME CORP | SYRON RICHARD F/CA | Director | Buy | M | 0.00 | 2,500 | 0 | 5,011 | 2.5 K to 5 K (+99.56 %) |
Jun 18 2010 | GENZ | GENZYME CORP | MCGILLICUDY CORNELIUS III | Director | Option Exercise | A | 51.52 | 7,125 | 367,080 | 7,125 | |
Jun 18 2010 | GENZ | GENZYME CORP | MCGILLICUDY CORNELIUS III | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
Jun 18 2010 | GENZ | GENZYME CORP | MCGILLICUDY CORNELIUS III | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Jun 18 2010 | GENZ | GENZYME CORP | MCGILLICUDY CORNELIUS III | Director | Buy | M | 0.00 | 2,500 | 0 | 5,000 | 2.5 K to 5 K (+100.00 %) |
Jun 18 2010 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 51.52 | 7,125 | 367,080 | 7,125 | |
Jun 18 2010 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
Jun 18 2010 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Jun 18 2010 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Buy | M | 0.00 | 2,500 | 0 | 5,000 | 2.5 K to 5 K (+100.00 %) |
Jun 18 2010 | GENZ | GENZYME CORP | COONEY CHARLES L | Director | Option Exercise | A | 51.52 | 7,125 | 367,080 | 7,125 | |
Jun 18 2010 | GENZ | GENZYME CORP | COONEY CHARLES L | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
Jun 18 2010 | GENZ | GENZYME CORP | COONEY CHARLES L | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Jun 18 2010 | GENZ | GENZYME CORP | COONEY CHARLES L | Director | Buy | M | 0.00 | 2,500 | 0 | 9,664 | 7.2 K to 9.7 K (+34.90 %) |
Jun 18 2010 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Option Exercise | A | 51.52 | 7,125 | 367,080 | 7,125 | |
Jun 18 2010 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
Jun 18 2010 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Jun 18 2010 | GENZ | GENZYME CORP | CARPENTER ROBERT J | Director | Buy | M | 0.00 | 2,500 | 0 | 31,825 | 29.3 K to 31.8 K (+8.53 %) |
Jun 18 2010 | GENZ | GENZYME CORP | BOUDREAUX GAIL | Director | Option Exercise | A | 51.52 | 7,125 | 367,080 | 7,125 | |
Jun 18 2010 | GENZ | GENZYME CORP | BOUDREAUX GAIL | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
Jun 18 2010 | GENZ | GENZYME CORP | BOUDREAUX GAIL | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Jun 18 2010 | GENZ | GENZYME CORP | BOUDREAUX GAIL | Director | Buy | M | 0.00 | 2,500 | 0 | 5,000 | 2.5 K to 5 K (+100.00 %) |
Jun 18 2010 | GENZ | GENZYME CORP | BERTOLINI ROBERT J | Director | Option Exercise | A | 51.52 | 7,125 | 367,080 | 7,125 | |
Jun 18 2010 | GENZ | GENZYME CORP | BERTOLINI ROBERT J | Director | Option Exercise | M | 0.00 | 2,375 | 0 | 0 | |
Jun 18 2010 | GENZ | GENZYME CORP | BERTOLINI ROBERT J | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Jun 18 2010 | GENZ | GENZYME CORP | BERTOLINI ROBERT J | Director | Buy | M | 0.00 | 2,375 | 0 | 2,375 | 0 to 2.4 K |
Jun 18 2010 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 51.52 | 7,125 | 367,080 | 7,125 | |
Jun 18 2010 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
Jun 18 2010 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Jun 18 2010 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Buy | M | 0.00 | 2,500 | 0 | 71,158 | 68.7 K to 71.2 K (+3.64 %) |
Jun 18 2010 | GENZ | GENZYME CORP | WIRTH PETER | Exec VP,Legal & Cor ... | Option Exercise | A | 51.52 | 42,750 | 2,202,480 | 42,750 | |
Jun 18 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | A | 51.52 | 42,750 | 2,202,480 | 42,750 | |
Jun 18 2010 | GENZ | GENZYME CORP | WYZGA MICHAEL S | Executive VP and CF ... | Option Exercise | A | 51.52 | 42,750 | 2,202,480 | 42,750 | |
Jun 18 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Option Exercise | A | 51.52 | 190,000 | 9,788,800 | 190,000 | |
Jun 18 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | A | 51.52 | 23,038 | 1,186,918 | 23,038 | |
Jun 18 2010 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | A | 51.52 | 23,038 | 1,186,918 | 23,038 | |
Jun 18 2010 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | A | 51.52 | 60,000 | 3,091,200 | 60,000 | |
Jun 18 2010 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | A | 51.52 | 14,250 | 734,160 | 14,250 | |
Jun 18 2010 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | A | 51.52 | 23,038 | 1,186,918 | 23,038 | |
Jun 18 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | A | 51.52 | 16,625 | 856,520 | 16,625 | |
Jun 18 2010 | GENZ | GENZYME CORP | Amello Jason | CorpContrllr,ChiefA ... | Option Exercise | A | 51.52 | 4,340 | 223,597 | 4,340 | |
Jun 18 2010 | GENZ | GENZYME CORP | Amello Jason | CorpContrllr,ChiefA ... | Option Exercise | A | 0.00 | 1,447 | 0 | 1,447 | |
Jun 18 2010 | GENZ | GENZYME CORP | Canute Scott A | Executive VP | Option Exercise | A | 51.52 | 42,750 | 2,202,480 | 42,750 | |
Jun 15 2010 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Sell | S | 48.81 | 1,000 | 48,810 | 4,356 | 5.4 K to 4.4 K (-18.67 %) |
Jun 01 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Sell | S | 49.54 | 1,737 | 86,051 | 37,210 | 38.9 K to 37.2 K (-4.46 %) |
May 26 2010 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | M | 0.00 | 8,083 | 0 | 0 | |
May 26 2010 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Sell | S | 45.60 | 2,732 | 124,579 | 10,045 | 12.8 K to 10 K (-21.38 %) |
May 26 2010 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Buy | M | 0.00 | 8,083 | 0 | 12,777 | 4.7 K to 12.8 K (+172.20 %) |
May 26 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | M | 0.00 | 5,833 | 0 | 0 | |
May 26 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | M | 0.00 | 1,944 | 0 | 1,944 | |
May 26 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Sell | S | 45.60 | 1,972 | 89,923 | 12,517 | 14.5 K to 12.5 K (-13.61 %) |
May 26 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Sell | S | 45.62 | 657 | 29,972 | 14,489 | 15.1 K to 14.5 K (-4.34 %) |
May 26 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Buy | M | 0.00 | 5,833 | 0 | 15,146 | 9.3 K to 15.1 K (+62.63 %) |
May 26 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Buy | M | 0.00 | 1,944 | 0 | 9,906 | 8 K to 9.9 K (+24.42 %) |
May 26 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
May 26 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | M | 0.00 | 5,000 | 0 | 5,000 | |
May 26 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Sell | S | 45.60 | 6,665 | 303,924 | 20,671 | 27.3 K to 20.7 K (-24.38 %) |
May 26 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Sell | S | 45.62 | 2,222 | 101,368 | 27,336 | 29.6 K to 27.3 K (-7.52 %) |
May 26 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Buy | M | 0.00 | 15,000 | 0 | 29,558 | 14.6 K to 29.6 K (+103.04 %) |
May 26 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Buy | M | 0.00 | 5,000 | 0 | 16,083 | 11.1 K to 16.1 K (+45.11 %) |
May 26 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | M | 0.00 | 8,083 | 0 | 0 | |
May 26 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | M | 0.00 | 2,694 | 0 | 2,695 | |
May 26 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Sell | S | 45.63 | 3,592 | 163,903 | 38,947 | 42.5 K to 38.9 K (-8.44 %) |
May 26 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Sell | S | 45.62 | 1,197 | 54,607 | 42,539 | 43.7 K to 42.5 K (-2.74 %) |
May 26 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Buy | M | 0.00 | 8,083 | 0 | 43,736 | 35.7 K to 43.7 K (+22.67 %) |
May 26 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Buy | M | 0.00 | 2,694 | 0 | 36,475 | 33.8 K to 36.5 K (+7.97 %) |
May 26 2010 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | M | 0.00 | 8,083 | 0 | 0 | |
May 26 2010 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Sell | S | 45.63 | 2,731 | 124,616 | 20,830 | 23.6 K to 20.8 K (-11.59 %) |
May 26 2010 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Buy | M | 0.00 | 8,083 | 0 | 23,561 | 15.5 K to 23.6 K (+52.22 %) |
May 26 2010 | GENZ | GENZYME CORP | Amello Jason | CorpContrllr,ChiefA ... | Option Exercise | M | 0.00 | 1,575 | 0 | 0 | |
May 26 2010 | GENZ | GENZYME CORP | Amello Jason | CorpContrllr,ChiefA ... | Sell | S | 45.62 | 533 | 24,315 | 3,270 | 3.8 K to 3.3 K (-14.02 %) |
May 26 2010 | GENZ | GENZYME CORP | Amello Jason | CorpContrllr,ChiefA ... | Buy | M | 0.00 | 1,575 | 0 | 4,336 | 2.8 K to 4.3 K (+57.04 %) |
May 26 2010 | GENZ | GENZYME CORP | WIRTH PETER | Exec VP,Legal & Cor ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
May 26 2010 | GENZ | GENZYME CORP | WIRTH PETER | Exec VP,Legal & Cor ... | Sell | S | 45.62 | 6,665 | 304,057 | 15,191 | 21.9 K to 15.2 K (-30.50 %) |
May 26 2010 | GENZ | GENZYME CORP | WIRTH PETER | Exec VP,Legal & Cor ... | Buy | M | 0.00 | 15,000 | 0 | 21,856 | 6.9 K to 21.9 K (+218.79 %) |
May 26 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Option Exercise | M | 0.00 | 67,000 | 0 | 0 | |
May 26 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Option Exercise | M | 0.00 | 22,333 | 0 | 22,334 | |
May 26 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Sell | S | 45.60 | 29,772 | 1,357,603 | 686,529 | 716.3 K to 686.5 K (-4.16 %) |
May 26 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Sell | S | 45.62 | 9,923 | 452,687 | 716,301 | 726.2 K to 716.3 K (-1.37 %) |
May 26 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Buy | M | 0.00 | 67,000 | 0 | 726,224 | 659.2 K to 726.2 K (+10.16 %) |
May 26 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Buy | M | 0.00 | 22,333 | 0 | 668,179 | 645.8 K to 668.2 K (+3.46 %) |
May 26 2010 | GENZ | GENZYME CORP | WYZGA MICHAEL S | Executive VP and CF ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
May 26 2010 | GENZ | GENZYME CORP | WYZGA MICHAEL S | Executive VP and CF ... | Sell | S | 45.63 | 5,068 | 231,253 | 24,024 | 29.1 K to 24 K (-17.42 %) |
May 26 2010 | GENZ | GENZYME CORP | WYZGA MICHAEL S | Executive VP and CF ... | Buy | M | 0.00 | 15,000 | 0 | 29,092 | 14.1 K to 29.1 K (+106.44 %) |
May 26 2010 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
May 26 2010 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Sell | S | 45.59 | 2,329 | 106,179 | 5,356 | 7.7 K to 5.4 K (-30.31 %) |
May 26 2010 | GENZ | GENZYME CORP | GERAGHTY JAMES A | Senior Vice Preside ... | Buy | M | 0.00 | 5,000 | 0 | 7,685 | 2.7 K to 7.7 K (+186.22 %) |
May 26 2010 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Option Exercise | M | 0.00 | 5,833 | 0 | 0 | |
May 26 2010 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Sell | S | 45.60 | 1,972 | 89,923 | 5,316 | 7.3 K to 5.3 K (-27.06 %) |
May 26 2010 | GENZ | GENZYME CORP | DesRosier Thomas | Sr VP, General Coun ... | Buy | M | 0.00 | 5,833 | 0 | 7,288 | 1.5 K to 7.3 K (+400.89 %) |
May 25 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Option Exercise | M | 0.00 | 4,750 | 0 | 9,500 | |
May 25 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Sell | S | 48.93 | 1,525 | 74,618 | 9,558 | 11.1 K to 9.6 K (-13.76 %) |
May 25 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Buy | M | 0.00 | 4,750 | 0 | 11,083 | 6.3 K to 11.1 K (+75.00 %) |
May 25 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn,President and ... | Option Exercise | M | 0.00 | 21,216 | 0 | 42,434 | |
May 25 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn,President and ... | Sell | S | 48.93 | 8,955 | 438,168 | 636,891 | 645.8 K to 636.9 K (-1.39 %) |
May 25 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn,President and ... | Buy | M | 0.00 | 21,216 | 0 | 645,846 | 624.6 K to 645.8 K (+3.40 %) |
May 25 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Option Exercise | M | 0.00 | 2,559 | 0 | 8,083 | |
May 25 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Sell | S | 48.93 | 822 | 40,220 | 32,959 | 33.8 K to 33 K (-2.43 %) |
May 25 2010 | GENZ | GENZYME CORP | SMITH ALAN E | Sr VP,Chief Scienti ... | Buy | M | 0.00 | 2,559 | 0 | 33,781 | 31.2 K to 33.8 K (+8.20 %) |
May 25 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Option Exercise | M | 0.00 | 1,847 | 0 | 5,833 | |
May 25 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Sell | S | 48.93 | 593 | 29,015 | 7,369 | 8 K to 7.4 K (-7.45 %) |
May 25 2010 | GENZ | GENZYME CORP | CSIMMA ZOLTAN A | SrVP,Chief Human Re ... | Buy | M | 0.00 | 1,847 | 0 | 7,962 | 6.1 K to 8 K (+30.20 %) |
May 19 2010 | GENZ | GENZYME CORP | WIRTH PETER | Exec VP,Legal & Cor ... | Option Exercise | M | 26.50 | 48,216 | 1,277,724 | 0 | |
May 19 2010 | GENZ | GENZYME CORP | WIRTH PETER | Exec VP,Legal & Cor ... | Sell | S | 50.51 | 48,216 | 2,435,390 | 6,856 | 55.1 K to 6.9 K (-87.55 %) |
May 19 2010 | GENZ | GENZYME CORP | WIRTH PETER | Exec VP,Legal & Cor ... | Buy | M | 26.50 | 48,216 | 1,277,724 | 55,072 | 6.9 K to 55.1 K (+703.27 %) |
May 25 2010 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Option Exercise | M | 26.50 | 16,488 | 436,932 | 0 | |
May 25 2010 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Sell | S | 49.06 | 16,488 | 808,901 | 4,694 | 21.2 K to 4.7 K (-77.84 %) |
May 25 2010 | GENZ | GENZYME CORP | Meeker David P | ExecVP,Chief Operat ... | Buy | M | 26.50 | 16,488 | 436,932 | 21,182 | 4.7 K to 21.2 K (+351.26 %) |
May 19 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Option Exercise | M | 26.50 | 100,000 | 2,650,000 | 0 | |
May 19 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Sell | S | 50.54 | 100,000 | 5,054,000 | 624,630 | 724.6 K to 624.6 K (-13.80 %) |
May 19 2010 | GENZ | GENZYME CORP | TERMEER HENRI A | Chmn, President and ... | Buy | M | 26.50 | 100,000 | 2,650,000 | 724,630 | 624.6 K to 724.6 K (+16.01 %) |
May 18 2010 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Option Exercise | M | 26.50 | 18,318 | 485,427 | 0 | |
May 18 2010 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Sell | S | 50.70 | 18,318 | 928,723 | 15,478 | 33.8 K to 15.5 K (-54.20 %) |
May 18 2010 | GENZ | GENZYME CORP | MOSCICKI RICHARD A | Sr VP,Chief Medical ... | Buy | M | 26.50 | 18,318 | 485,427 | 33,796 | 15.5 K to 33.8 K (+118.35 %) |
Apr 16 2010 | GENZ | GENZYME CORP | WHITWORTH RALPH V | Director | Option Exercise | A | 52.66 | 7,125 | 375,203 | 7,125 | |
Apr 16 2010 | GENZ | GENZYME CORP | WHITWORTH RALPH V | Director | Option Exercise | A | 0.00 | 2,375 | 0 | 2,375 | |
Apr 02 2010 | GENZ | GENZYME CORP | BERTHIAUME DOUGLAS A | Director | Option Exercise | A | 0.00 | 511 | 0 | 511 | |
Apr 02 2010 | GENZ | GENZYME CORP | DZAU VICTOR J | Director | Option Exercise | A | 0.00 | 499 | 0 | 499 | |
Mar 23 2010 | GENZ | GENZYME CORP | SMITH SANDFORD D | Exe VP,President In ... | Sell | S | 58.90 | 3,359 | 197,845 | 6,278 | 9.6 K to 6.3 K (-34.86 %) |